BR112014009223A2 - método para o diagnóstico da doença de niemann-pick - Google Patents
método para o diagnóstico da doença de niemann-pickInfo
- Publication number
- BR112014009223A2 BR112014009223A2 BR112014009223A BR112014009223A BR112014009223A2 BR 112014009223 A2 BR112014009223 A2 BR 112014009223A2 BR 112014009223 A BR112014009223 A BR 112014009223A BR 112014009223 A BR112014009223 A BR 112014009223A BR 112014009223 A2 BR112014009223 A2 BR 112014009223A2
- Authority
- BR
- Brazil
- Prior art keywords
- niemann
- pick disease
- diagnosis
- subject
- pick
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
- G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
resumo patente de invenção: "método para o diagnóstico da doença de niemann-pick". a presente invenção refere-se a um método para o diagnóstico da doença de niemann-pick em um sujeito compreendendo uma etapa a), em que a etapa a) compreende detecção de um biomarcador em uma amostra do sujeito.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11009062 | 2011-11-15 | ||
EP11009062.8 | 2011-11-15 | ||
PCT/EP2012/004756 WO2013072060A2 (en) | 2011-11-15 | 2012-11-15 | Method for the diagnosis of niemann-pick disease |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112014009223A2 true BR112014009223A2 (pt) | 2017-06-13 |
BR112014009223A8 BR112014009223A8 (pt) | 2017-06-20 |
BR112014009223B1 BR112014009223B1 (pt) | 2021-04-06 |
Family
ID=47221301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014009223-0A BR112014009223B1 (pt) | 2011-11-15 | 2012-11-15 | Métodos para o diagnóstico da doença de niemann-pick, método para determinação do curso da doença de niemann-pick, método para determinação da eficácia de pelo menos um tratamento, uso de análise espectrométrica de massa e kit |
Country Status (11)
Country | Link |
---|---|
US (4) | US9910033B2 (pt) |
EP (1) | EP2780716B1 (pt) |
JP (2) | JP6243846B2 (pt) |
AU (3) | AU2012339149A1 (pt) |
BR (1) | BR112014009223B1 (pt) |
CA (1) | CA2854668A1 (pt) |
CY (1) | CY1122360T1 (pt) |
DK (1) | DK2780716T3 (pt) |
IL (1) | IL231982B (pt) |
MX (1) | MX359328B (pt) |
WO (1) | WO2013072060A2 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9983200B2 (en) | 2013-03-14 | 2018-05-29 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Compositions and methods for predicting age of onset of a lysosomal storage disease or a disease associated with a lysosomal defect |
SG11201509622WA (en) * | 2013-06-07 | 2015-12-30 | Genzyme Corp | Marker for acid sphingomyelinase disorders and uses thereof |
CA3002526A1 (en) | 2014-10-28 | 2016-05-06 | Washington University | Bile acid biomarkers for niemann-pick diseases, methods and uses therefor |
EP3221705A1 (en) * | 2014-11-19 | 2017-09-27 | Centogene AG | Method for the diagnosis of niemann-pick disease using a biomarker |
US10656059B2 (en) | 2018-03-07 | 2020-05-19 | Alcala Pharmaceutical, Inc. | Method for qualitative and quantitative multiplexing of drug analytes from biological samples |
EP3803412A1 (en) * | 2018-06-01 | 2021-04-14 | Laboratory Corporation of America Holdings | Simplified biosample processing for lc-ms/ms |
CN111289647A (zh) * | 2020-03-09 | 2020-06-16 | 广州市妇女儿童医疗中心(广州市妇幼保健院、广州市儿童医院、广州市妇婴医院、广州市妇幼保健计划生育服务中心) | 葡糖鞘氨醇的检测方法 |
WO2024026390A2 (en) * | 2022-07-28 | 2024-02-01 | Wylder Nation Foundation | Compositions and methods for diagnosing, treating, and preventing lysosomal storage diseases |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4498918B2 (ja) * | 2002-04-30 | 2010-07-07 | 生化学工業株式会社 | リソソーム病の検出方法 |
US8497122B2 (en) * | 2008-04-11 | 2013-07-30 | Washington University | Biomarkers for Niemann-pick C disease and related disorders |
US8313949B2 (en) | 2009-04-16 | 2012-11-20 | Nextcea Inc. | Detecting phospholipidosis and diagnosing lysosomal storage disorders |
KR20230164773A (ko) | 2009-08-28 | 2023-12-04 | 이칸 스쿨 오브 메디슨 엣 마운트 시나이 | 산성 스핑고미엘리나제 결핍을 치료하기 위한 투여량 단계적 증가 효소 대체 요법 |
-
2012
- 2012-11-15 DK DK12790426.6T patent/DK2780716T3/da active
- 2012-11-15 BR BR112014009223-0A patent/BR112014009223B1/pt active IP Right Grant
- 2012-11-15 EP EP12790426.6A patent/EP2780716B1/en active Active
- 2012-11-15 AU AU2012339149A patent/AU2012339149A1/en not_active Abandoned
- 2012-11-15 MX MX2014005923A patent/MX359328B/es active IP Right Grant
- 2012-11-15 WO PCT/EP2012/004756 patent/WO2013072060A2/en active Application Filing
- 2012-11-15 JP JP2014541566A patent/JP6243846B2/ja active Active
- 2012-11-15 CA CA2854668A patent/CA2854668A1/en active Pending
- 2012-11-15 US US14/358,669 patent/US9910033B2/en active Active
-
2014
- 2014-04-07 IL IL231982A patent/IL231982B/en active IP Right Grant
-
2017
- 2017-09-11 US US15/700,949 patent/US10422789B2/en active Active
- 2017-11-10 JP JP2017216846A patent/JP6711807B2/ja active Active
-
2018
- 2018-09-12 AU AU2018229451A patent/AU2018229451B2/en active Active
-
2019
- 2019-08-15 US US16/541,716 patent/US11231412B2/en active Active
- 2019-10-30 CY CY20191101122T patent/CY1122360T1/el unknown
-
2021
- 2021-06-29 AU AU2021204429A patent/AU2021204429B2/en not_active Expired - Fee Related
- 2021-12-22 US US17/558,640 patent/US11841362B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2021204429A1 (en) | 2021-07-29 |
AU2021204429B2 (en) | 2024-01-25 |
AU2018229451A1 (en) | 2018-10-04 |
CA2854668A1 (en) | 2013-05-23 |
US20140309140A1 (en) | 2014-10-16 |
US10422789B2 (en) | 2019-09-24 |
MX2014005923A (es) | 2014-09-08 |
CY1122360T1 (el) | 2021-01-27 |
US11841362B2 (en) | 2023-12-12 |
US20220187283A1 (en) | 2022-06-16 |
AU2012339149A1 (en) | 2014-04-24 |
JP2018054620A (ja) | 2018-04-05 |
US9910033B2 (en) | 2018-03-06 |
AU2018229451B2 (en) | 2021-04-01 |
US11231412B2 (en) | 2022-01-25 |
US20200072819A1 (en) | 2020-03-05 |
JP6711807B2 (ja) | 2020-06-17 |
JP6243846B2 (ja) | 2017-12-06 |
DK2780716T3 (da) | 2019-10-14 |
EP2780716B1 (en) | 2019-07-31 |
US20180088107A1 (en) | 2018-03-29 |
WO2013072060A2 (en) | 2013-05-23 |
BR112014009223B1 (pt) | 2021-04-06 |
MX359328B (es) | 2018-09-25 |
IL231982B (en) | 2020-01-30 |
EP2780716A2 (en) | 2014-09-24 |
AU2012339149A8 (en) | 2014-05-08 |
WO2013072060A8 (en) | 2014-07-17 |
JP2014533367A (ja) | 2014-12-11 |
BR112014009223A8 (pt) | 2017-06-20 |
WO2013072060A3 (en) | 2013-07-25 |
IL231982A0 (en) | 2014-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014009223A2 (pt) | método para o diagnóstico da doença de niemann-pick | |
EA201590027A1 (ru) | Способы детекции заболеваний или состояний | |
BR112014010955A2 (pt) | sistema e método para processar amostras | |
CL2013001883A1 (es) | Metodo de inmunoensayo para vitamina d; inmunoensayo para detectar vitamina 25-oh d en sangre. | |
BR112015018463A2 (pt) | Biomarcadores de diabetes tipo 2 e usos dos mesmos | |
BR112014009643A2 (pt) | métodos para diagnosticar ou detectar neoplasia colorretal em um sujeito humano, biomarcador para progressão de doença e kits para um diagnóstico de neoplasia colorretal | |
BRPI1009343A2 (pt) | método realizado por hardware que executa software, e, mídia legível por computador não temporária | |
BR112013023540A2 (pt) | anticorpo, kit e método para a determinação de peptídeos amilóides | |
BR112012030587A2 (pt) | métodos para diagnóstico de câncer pancreático, para identificar se um indivíduo precisa ou não de uma terapia contra câncer pancreático e para determinar se uma terapia contra câncer pancreático obtém sucesso, dispositivo para diagnóstico de câncer pancreático e uso de pelo menos um biomarcador | |
AR088083A1 (es) | USO DE ANTICUERPOS DE UNION A IL-1b | |
BR112015014232A2 (pt) | lesão renal aguda | |
BR112013026482A2 (pt) | captura de amostra em uma única etapa para tiras de teste | |
EA201591742A1 (ru) | Способ улучшения диагностики заболеваний с использованием измеряемых аналитов | |
WO2013023144A3 (en) | Diagnostic biomarker profiles for the detection and diagnosis of parkinsons disease | |
CR20110530A (es) | Dispositivo y procedimiento para la verificación y para el análisis cuantitativo de analitos, particularmente de micotoxinas | |
WO2015013508A3 (en) | Methods for diagnosing and treating immune disease | |
MX2016001719A (es) | Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular. | |
BR112013031431A2 (pt) | método para o diagnóstico da doença de gaucher | |
GB201201766D0 (en) | Method | |
BR112015027249A2 (pt) | método de diagnóstico de câncer | |
BR112017027304A2 (pt) | método para o diagnóstico de doença de farber | |
GB201114909D0 (en) | Biomarkers for lysosomal storage disorders | |
BR112015013498A2 (pt) | método para o diagnóstico de leucodistrofia metacromática | |
BR112014006296A2 (pt) | método para detectar um analito | |
BR112012007557A2 (pt) | alterações anormais de processamento de isozimas de pkc em células periféricas da doença de alzheimer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: CENTOGENE AG (DE) |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B25G | Requested change of headquarter approved |
Owner name: CENTOGENE AG (DE) |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B25D | Requested change of name of applicant approved |
Owner name: CENTOGENE GMBH (DE) |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/11/2012, OBSERVADAS AS CONDICOES LEGAIS. |